These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 1740749)
1. Pharmacokinetics of single and chronic dose zidovudine in two HIV positive patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Gallicano KD; Tobe S; Sahai J; McGilveray IJ; Cameron DW; Kriger F; Garber G J Acquir Immune Defic Syndr (1988); 1992; 5(3):242-50. PubMed ID: 1740749 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of orally administered zidovudine among patients with hemophilia and asymptomatic human immunodeficiency virus (HIV) infection. Morse GD; Olson J; Portmore A; Taylor C; Plank C; Reichman RC Antiviral Res; 1989 Mar; 11(2):57-65. PubMed ID: 2729955 [TBL] [Abstract][Full Text] [Related]
3. Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients. Morse GD; Portmore AC; Marder V; Plank C; Olson J; Taylor C; Bonnez W; Reichman RC Antimicrob Agents Chemother; 1992 Oct; 36(10):2245-52. PubMed ID: 1444306 [TBL] [Abstract][Full Text] [Related]
4. Zidovudine pharmacokinetics in zidovudine-induced bone marrow toxicity. Barry M; Howe JL; Back DJ; Swart AM; Breckenridge AM; Weller IV; Beeching N; Nye F Br J Clin Pharmacol; 1994 Jan; 37(1):7-12. PubMed ID: 8148221 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062). Moore KH; Raasch RH; Brouwer KL; Opheim K; Cheeseman SH; Eyster E; Lemon SM; van der Horst CM Antimicrob Agents Chemother; 1995 Dec; 39(12):2732-7. PubMed ID: 8593010 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients. Brockmeyer NH; Tillmann I; Mertins L; Barthel B; Goos M Eur J Med Res; 1997 Sep; 2(9):377-83. PubMed ID: 9300934 [TBL] [Abstract][Full Text] [Related]
7. Zidovudine pharmacokinetics in five HIV seronegative patients undergoing continuous ambulatory peritoneal dialysis. Kremer D; Munar MY; Kohlhepp SJ; Swan SK; Stinnett EA; Gilbert DN; Young EW; Bennett WM Pharmacotherapy; 1992; 12(1):56-60. PubMed ID: 1549540 [TBL] [Abstract][Full Text] [Related]
8. Impaired absorption of zidovudine in patients with AIDS-related small intestinal disease. Kapembwa MS; Fleming SC; Orr M; Wells C; Bland M; Back D; Griffin GE AIDS; 1996 Nov; 10(13):1509-14. PubMed ID: 8931785 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of zidovudine in HIV-positive patients with liver disease. Bareggi SR; Cinque P; Mazzei M; D'Arminio A; Ruggieri A; Pirola R; Nicolin A; Lazzarin A J Clin Pharmacol; 1994 Jul; 34(7):782-6. PubMed ID: 7929874 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome. Barry M; Howe JL; Ormesher S; Back DJ; Breckenridge AM; Bergin C; Mulcahy F; Beeching N; Nye F Br J Clin Pharmacol; 1994 May; 37(5):421-6. PubMed ID: 8054247 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of zidovudine in end-stage renal disease: influence of haemodialysis. Pachon J; Cisneros JM; Castillo JR; Garcia-Pesquera F; Cañas E; Viciana P AIDS; 1992 Aug; 6(8):827-30. PubMed ID: 1418779 [TBL] [Abstract][Full Text] [Related]
12. Single- and multiple-dose kinetics of ofloxacin in patients on continuous ambulatory peritoneal dialysis (CAPD). Passlick J; Wonner R; Keller E; Essers L; Grabensee B Perit Dial Int; 1989; 9(4):267-72. PubMed ID: 2488379 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of oral zidovudine administered during labour: a preliminary study. Mirochnick M; Rodman JH; Robbins BL; Fridland A; Gandía J; Hitti J; Bardeguez A; Rathore MH; Gonzalez Garcia A; Cababasay M; Samson P; Mofenson L; Bryson YJ; Dorenbaum A HIV Med; 2007 Oct; 8(7):451-6. PubMed ID: 17760737 [TBL] [Abstract][Full Text] [Related]
15. Lack of pharmacokinetic interaction between amdoxovir and reduced- and standard-dose zidovudine in HIV-1-infected individuals. Hurwitz SJ; Asif G; Fromentin E; Tharnish PM; Schinazi RF Antimicrob Agents Chemother; 2010 Mar; 54(3):1248-55. PubMed ID: 20038617 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of simultaneously administered zidovudine and didanosine in HIV-seropositive male patients. Sahai J; Gallicano K; Garber G; Pakuts A; Cameron W J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):54-60. PubMed ID: 7648285 [TBL] [Abstract][Full Text] [Related]
17. Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells. Robbins BL; Rodman J; McDonald C; Srinivas RV; Flynn PM; Fridland A Antimicrob Agents Chemother; 1994 Jan; 38(1):115-21. PubMed ID: 7511360 [TBL] [Abstract][Full Text] [Related]
18. The effects of indomethacin and naproxen on zidovudine pharmacokinetics. Barry M; Howe J; Back D; Breckenridge A; Brettle R; Mitchell R; Beeching NJ; Nye FJ Br J Clin Pharmacol; 1993 Jul; 36(1):82-5. PubMed ID: 8373716 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of high-dose zidovudine administered as a continuous infusion in patients with cancer. Marchbanks K; Dudley MN; Posner MR; Darnowski J Pharmacotherapy; 1995; 15(4):451-7. PubMed ID: 7479197 [TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis (CAPD). Walker SE; Paton TW; Churchill DN; Ojo B; Manuel MA; Wright N Perit Dial Int; 1989; 9(1):51-5. PubMed ID: 2488182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]